Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease

Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease

US Patent 6858613 · Granted Feb 22, 2005

Estimated economic value: $353,517,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Techniques for indicating gun state information2025
Systems for managing an energy store at a gun2025
Inhibitors of (αv)(β6) integrin2025
GLP-1 receptor agonists and uses thereof2025
GLP-1 receptor agonists and uses thereof2025
GLP-1 receptor agonists and uses thereof2025
Pyrrolopyrimidine ITK inhibitors2025
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the s2025
Antagonists of human integrin α4β72025
Inhibitors of (α-v)(β-6) integrin2024
Chemical compounds2024
Heteroaromatic compounds and their use as dopamine D1 ligands2024